Walleye Capital’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Buy |
24,929
+24,210
| +3,367% | +$339K | ﹤0.01% | 1193 |
|
|
2025
Q1 | $11.2K | Buy |
+719
| New | +$11.2K | ﹤0.01% | 1724 |
|
|
2024
Q1 | – | Sell |
-323,600
| Closed | -$1.05M | – | 2632 |
|
|
2023
Q4 | $1.05M | Buy |
+323,600
| New | +$1.05M | ﹤0.01% | 877 |
|
|
2022
Q2 | – | Sell |
-75,553
| Closed | -$1.46M | – | 2286 |
|
|
2022
Q1 | $1.46M | Sell |
75,553
-7,867
| -9% | -$152K | 0.04% | 448 |
|
|
2021
Q4 | $1.73M | Buy |
+83,420
| New | +$1.73M | 0.05% | 355 |
|